DR. YELDA NOURI M.D. NPI 1073803557

NPI Details

DR. Yelda Nouri, M.D. is a hematology and oncology internal medicine in Riverhead, NY with 18 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Yelda Nouri, M.D. NPI is 1073803557. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

750 OLD COUNTRY ROAD BUILDING 2
RIVERHEAD, NY
ZIP 11901
Phone: (631) 751-3000
Fax: (631) 509-6559

The NPI 1073803557 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Phosphate level (HCPCS:84100)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Magnesium level (HCPCS:83735)
• Uric acid level, blood (HCPCS:84550)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Vitamin d-3 level (HCPCS:82306)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Red blood count, manual test (HCPCS:85044)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Protein measurement, serum (HCPCS:84165)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Folic acid level, serum (HCPCS:82746)
• Injection of drug or substance into vein (HCPCS:96374)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Blood test, clotting time (HCPCS:85610)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Measurement c-reactive protein for detection of infection or inflammation, high sensitivity (HCPCS:86141)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Hemoglobin a1c level (HCPCS:83036)
• Ige (immune system protein) level (HCPCS:82785)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Acute hepatitis panel (HCPCS:80074)
• Testosterone (hormone) level, total (HCPCS:84403)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Urinalysis, manual test (HCPCS:81002)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Drawing of blood for a medical problem (HCPCS:99195)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Injection, ertapenem sodium, 500 mg (HCPCS:J1335)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99426)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Blood test, basic group of blood chemicals (calcium, ionized) (HCPCS:80047)
• Bilirubin level, total (HCPCS:82247)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Red blood cell concentration measurement (HCPCS:85014)
• Rheumatoid factor level (HCPCS:86431)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Cholesterol level (HCPCS:82465)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Liver function blood test panel (HCPCS:80076)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
• Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
• Gene analysis (calreticulin), common variants (HCPCS:81219)
• Gene analysis (janus kinase 2) variant (HCPCS:81270)
• Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
• Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants (HCPCS:81338)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Molecular pathology procedure; physician interpretation and report (HCPCS:G0452)
• Flow cytometry technique for dna or cell analysis, 16 or more markers (HCPCS:88189)
• Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
• Blood creatinine level (HCPCS:82565)
• Calcium level, total (HCPCS:82310)

The enumeration date for this NPI number is 4/18/2011 and was last updated on 2/3/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: